Tag: Pfizer

Pfizer Australia is investing AUD 150 million to upgrade its Melbourne facility into one of the country’s most advanced pharmaceutical production sites to combat antimicrobial resistance (AMR).

An international research collaboration, spearheaded by Pfizer in partnership with Monash University and the Cancer Therapeutics Cooperative Research Centre in Australia, has identified a promising pre-clinical drug candidate with potential anti-tumour activity against Estrogen Receptor (ER) positive breast cancer.

Global pharmaceutical company Bridgewest is set to expand its operations in Bentley, transforming the former Pfizer-owned facility into a hub for medical product manufacturing, owing to a $2 million investment from the Western Australian Government.

Global private investment firm Bridgewest Group has completed the acquisition of the Perth sterile injectable manufacturing facility from Pfizer. 

The Victorian government is backing a fellowship that will support a Victorian researcher to work at Pfizer’s Emerging Science and Innovation Unit RNA Accelerator in the United States in 2023. 

An international collaboration between scientists from India and Australia is edging closer to delivering a ‘warm’ COVID-19 vaccine suitable for remote and resource-limited locations...

Two global pharmaceutical firms have teamed up with Australian research institutions to develop new treatments and drugs to fight cancer. German pharma giant Boehringer Ingelheim...

In light of recent AstraZeneca approval for use in Australia, the political party reiterated the need to further diversify jab availability in the country. The...

US-based pharmaceutical company Pfizer will cut down manufacturing time of its COVID-19 vaccines by half – from 110 days to an average of 60...

Last November, global biopharmaceutical giant Pfizer and Botox maker Allergan announced an all-stock $160 billion merger that would have resulted in the creation of...